Key Highlights
- GLP-1 injections added to Hims & Hers’ weight loss options
- Personalized weight loss treatments with medical support
- Access to medications with the same active ingredients as Ozempic® and Wegovy®
- Partnership with leading US manufacturer for high-quality compounded injectables
- Holistic weight management combining medications and lifestyle changes
Source: Business Wire
Notable Quotes
- “The core of our business is to offer a truly personalized experience that customers can trust and rely on. We’ve leveraged our size and scale to secure access to one of the highest-quality supplies of compounded GLP-1 injections available today.” – Andrew Dudum, CEO and co-founder at Hims & Hers
- “Our comprehensive approach to weight loss comes with support from medical providers who understand the nuance of weight gain and weight loss. We design all of our solutions to help customers be successful in the long term, and that means providing an experience personalized to the individual.” – Dr. Patrick Carroll, Chief Medical Officer at Hims & Hers
SoHC's Take
Hims & Hers’ latest addition of GLP-1 injections to their weight loss portfolio demonstrates their commitment to providing accessible and personalized healthcare solutions. By partnering with a leading manufacturer for high-quality compounded injectables, they address current market shortages and high costs associated with branded medications like Ozempic® and Wegovy®. This strategic move not only enhances their service offerings but also aligns with their mission to offer comprehensive and tailored health and wellness treatments. The holistic approach that combines medication with lifestyle changes further underscores their dedication to long-term customer success. As the weight loss market continues to grow, Hims & Hers is well-positioned to lead with innovative and customer-centric solutions.
